Dynamic Behaviour in Microcompartments

Compartmentalisation is recognised to be a primary step for the assembly of non-living matter towards the construction of life-like microensembles. To date, a host of hollow microcompartments with various functionalities have been widely developed. Within this respect, given that dynamic behaviour is one of the fundamental features to distinguish living ensembles from those that are non-living, the design and construction of microcompartments with various dynamic behaviours are attracting considerable interest from a wide range of research communities. Significantly, the created dynamic microcompartments could also be widely used as chassis for further bottom-up design towards building protocell models by integrating and booting up necessary biological information. Herein, strategies to install the various motility behaviours into microcompartments, including haptotaxis, chemotaxis and gravitaxis, are summarized in the anticipation of inspiring more designs towards creating various advanced active microcompartments, and contributing new techniques to the ultimate goal of constructing a basic living unit entirely from non-living components.

Neurotrophin delivery using nanotechnology

Deficits or overexpression of neurotrophins cause neurodegenerative diseases and psychiatric disorders. These proteins are required for the maintenance of the function, plasticity and survival of neurons in the central (CNS) and peripheral nervous systems. Significant efforts have been devoted to developing therapeutic delivery systems that enable control of neurotrophin dosage in the brain. Here, we suggest that nanoparticulate carriers favoring targeted delivery in specific brain areas and minimizing biodistribution to the systemic circulation should be developed toward clinical benefits of neuroregeneration. We also provide examples of improved targeted neurotrophin delivery to localized areas in the CNS.

From molecular to nanotechnology strategies for delivery of neurotrophins: emphasis on brain-derived neurotrophic factor (BDNF)

Neurodegenerative diseases represent a major public health problem, but beneficial clinical treatment with neurotrophic factors has not been established yet. The therapeutic use of neurotrophins has been restrained by their instability and rapid degradation in biological medium. A variety of strategies has been proposed for the administration of these leading therapeutic candidates, which are essential for the development, survival and function of human neurons. In this review, we describe the existing approaches for delivery of brain-derived neurotrophic factor (BDNF), which is the most abundant neurotrophin in the mammalian central nervous system (CNS). Biomimetic peptides of BDNF have emerged as a promising therapy against neurodegenerative disorders. Polymer-based carriers have provided sustained neurotrophin delivery, whereas lipid-based particles have contributed also to potentiation of the BDNF action. Nanotechnology offers new possibilities for the design of vehicles for neuroprotection and neuroregeneration. Recent developments in nanoscale carriers for encapsulation and transport of BDNF are highlighted.

Magnetophoresis at the nanoscale: tracking the magnetic targeting efficiency of nanovectors

Aim: Most of the research efforts in magnetic targeting have been focused on the development of magnetic nanovectors, while the investigation of methods for tracking their magnetic targeting efficiency remains inappropriately addressed. We propose herein a miniaturized approach for appraising magnetophoretic mobility at the nanoscale. Materials & methods: A simple and easy-to-use chamber including a microtip as a magnetic attractor was developed to perform magnetophoretic measurement at the size scale of nano-objects, and under bright field or fluorescence microscopy. Different sets of magnetic nanocontainers were produced and their magnetophoretic mobility was investigated. Real-time observations of the Brownian motion of the nanocontainers were also carried out for simultaneous size determination. Results: Attraction of the nanocontainers at the microtip is demonstrated as a qualitative method that immediately distinguishes magnetically responsive nano-objects. The combination of the analysis of Brownian motion, together with the magnetophoretic mobility, inferred both the size, the magnetophoretic velocity and the magnetic content of the nanocontainers. Additionally, nanomagnetophoresis experiments under fluorescence microscopy provided information on the constitutive core/shell integrity of the nanocontainers and the co-internalization of a fluorescent cargo. Conclusion: This nanomagnetophoresis method represents a promising tool to estimate the feasibility of magnetic targeting in laboratory routine.

Original submitted 28 November 2011; Revised submitted 28 February 2012; Published online 18 June 2012